GW Pharma Exceeds Expectations with $108 Million Preliminary Unaudited Revenue in 4th Quarter

GW Pharma Exceeds Expectations with $108 Million Preliminary Unaudited Revenue in 4th Quarter

New Cannabis Ventures     •     January 12, 2020, 11:29 pm

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales Total preliminary net product sales of approximately $108 million for the fourth quarter and…

http://htccbdhemp.com/